JP2017095440A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017095440A5 JP2017095440A5 JP2016181594A JP2016181594A JP2017095440A5 JP 2017095440 A5 JP2017095440 A5 JP 2017095440A5 JP 2016181594 A JP2016181594 A JP 2016181594A JP 2016181594 A JP2016181594 A JP 2016181594A JP 2017095440 A5 JP2017095440 A5 JP 2017095440A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- excipient
- concentration
- formulation
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222067P | 2015-09-22 | 2015-09-22 | |
| US62/222067 | 2015-09-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017095440A JP2017095440A (ja) | 2017-06-01 |
| JP2017095440A5 true JP2017095440A5 (https=) | 2019-10-24 |
| JP6925111B2 JP6925111B2 (ja) | 2021-08-25 |
Family
ID=57045234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016181594A Expired - Fee Related JP6925111B2 (ja) | 2015-09-22 | 2016-09-16 | 治療用タンパク質製剤を調製する方法、およびそのような方法により生成される抗体製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230134160A1 (https=) |
| EP (1) | EP3352790A1 (https=) |
| JP (1) | JP6925111B2 (https=) |
| KR (2) | KR20200035496A (https=) |
| CN (1) | CN108025072A (https=) |
| AU (1) | AU2016329034B2 (https=) |
| CA (1) | CA2999118C (https=) |
| HK (1) | HK1255006A1 (https=) |
| IL (1) | IL258311B (https=) |
| MX (1) | MX2018003298A (https=) |
| WO (1) | WO2017051273A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019517473A (ja) | 2016-05-27 | 2019-06-24 | アレクシオン ファーマシューティカルズ インコーポレイテッドＡｌｅｘｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 難治性全身型重症筋無力症の処置のための方法 |
| CA3080187A1 (en) | 2017-10-26 | 2019-05-02 | Alexion Pharmaceuticals, Inc. | Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) and atypical hemolytic uremic syndrome (ahus) |
| MX420109B (es) | 2018-03-26 | 2025-02-10 | Boehringer Ingelheim Animal Health Usa Inc | Metodo para producir una composicion inmunogenica |
| US11103552B2 (en) | 2018-05-10 | 2021-08-31 | Regeneron Pharmaceuticals, Inc. | High concentration VEGF receptor fusion protein containing formulations |
| WO2020006266A1 (en) | 2018-06-28 | 2020-01-02 | Alexion Pharmaceuticals, Inc. | Methods of producing anti-c5 antibodies |
| KR102893280B1 (ko) * | 2018-08-14 | 2025-12-01 | 브리스톨-마이어스 스큅 컴퍼니 | 개선된 단백질 회수 |
| CN111110841A (zh) * | 2018-10-31 | 2020-05-08 | 上海君实生物医药科技股份有限公司 | 含有抗pcsk9抗体的稳定制剂 |
| EP3858422B1 (en) | 2019-01-24 | 2022-11-02 | Magenta Medical Ltd. | Ventricular assist device |
| TWI871300B (zh) * | 2019-01-28 | 2025-02-01 | 美商安進公司 | 藉由將藥物物質和藥物產品過程整體化的生物製劑製造之連續製造過程 |
| KR102735988B1 (ko) | 2019-02-18 | 2024-12-03 | 일라이 릴리 앤드 캄파니 | 치료 항체 제제 |
| WO2021171310A1 (en) * | 2020-02-24 | 2021-09-02 | Indian Institute Of Technology Delhi | A system for real-time monitoring of protein and excipients |
| CN111944046B (zh) * | 2020-08-28 | 2021-04-09 | 江苏荃信生物医药有限公司 | 高浓度、低粘度抗人il-23单克隆抗体溶液的制备方法 |
| WO2022041390A1 (zh) * | 2020-08-28 | 2022-03-03 | 江苏荃信生物医药股份有限公司 | 包含高浓度抗人白介素23单克隆抗体的低粘度液体制剂及其制备方法 |
| JP2024505128A (ja) * | 2020-12-30 | 2024-02-05 | アイ－エムエービー バイオファーマ カンパニー リミテッド | 抗ｃｄ７３抗体の製剤 |
| CN114014929B (zh) * | 2021-11-04 | 2022-07-19 | 江苏荃信生物医药股份有限公司 | 一种抗人白介素-33单克隆抗体浓缩溶液的制备方法 |
| EP4467828A3 (en) | 2022-09-14 | 2025-02-12 | Magenta Medical Ltd. | Coupling between shaft and drive cable |
| WO2024165043A1 (en) * | 2023-02-08 | 2024-08-15 | Beigene Switzerland Gmbh | Preparation methods for a highly concentrated pd1 antibody solution by applying single-pass tangential flow filtration (sptff) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9415102B2 (en) * | 2002-09-06 | 2016-08-16 | Alexion Pharmaceuticals, Inc. | High concentration formulations of anti-C5 antibodies |
| US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| EP1871806A2 (en) * | 2005-03-08 | 2008-01-02 | Pharmacia & Upjohn Company LLC | ANTI-MAdCAM ANTIBODY COMPOSITIONS |
| JP2010512356A (ja) * | 2006-12-11 | 2010-04-22 | エフ．ホフマン−ラ ロシュ アーゲー | 非経口ａベータ抗体製剤 |
| US20090208492A1 (en) * | 2007-06-14 | 2009-08-20 | Elan Pharmaceuticals, Inc. | Lyophilized Immunoglobulin Formulations and Methods of Preparation |
| WO2010042705A1 (en) * | 2008-10-09 | 2010-04-15 | Medimmune, Llc | Antibody formulation |
| DK2538968T3 (en) * | 2010-02-24 | 2017-12-11 | Chiesi Farm Spa | PROCEDURE FOR THE PREPARATION AND PURIFICATION OF RECOMBINANT LYSOSOMAL ALFA MANNOSIDASE |
| AR080291A1 (es) * | 2010-02-24 | 2012-03-28 | Rinat Neuroscience Corp | Anticuerpos antagonistas anti receptor de il-7 y procedimientos |
| WO2012168491A1 (en) * | 2011-06-10 | 2012-12-13 | Novartis Ag | Pharmaceutical formulations of pcsk9 antagonists |
| EP2583980A1 (en) * | 2011-10-19 | 2013-04-24 | Effimune | Antibodies directed against the alpha chain of IL7 receptor - their use for the preparation of drug candidates |
| CN104271600B (zh) * | 2012-05-14 | 2018-09-14 | 诺和诺德股份有限公司 | 稳定化的蛋白溶液 |
| US9592297B2 (en) * | 2012-08-31 | 2017-03-14 | Bayer Healthcare Llc | Antibody and protein formulations |
| EP2727602A1 (en) * | 2012-10-31 | 2014-05-07 | Takeda GmbH | Method for preparation of a high concentration liquid formulation of an antibody |
-
2016
- 2016-09-08 US US15/761,777 patent/US20230134160A1/en active Pending
- 2016-09-08 HK HK18114122.2A patent/HK1255006A1/zh unknown
- 2016-09-08 CN CN201680054397.XA patent/CN108025072A/zh active Pending
- 2016-09-08 MX MX2018003298A patent/MX2018003298A/es unknown
- 2016-09-08 KR KR1020207008879A patent/KR20200035496A/ko not_active Ceased
- 2016-09-08 CA CA2999118A patent/CA2999118C/en active Active
- 2016-09-08 AU AU2016329034A patent/AU2016329034B2/en not_active Ceased
- 2016-09-08 KR KR1020187007855A patent/KR20180037056A/ko not_active Ceased
- 2016-09-08 EP EP16774987.8A patent/EP3352790A1/en active Pending
- 2016-09-08 WO PCT/IB2016/055355 patent/WO2017051273A1/en not_active Ceased
- 2016-09-16 JP JP2016181594A patent/JP6925111B2/ja not_active Expired - Fee Related
-
2018
- 2018-03-22 IL IL258311A patent/IL258311B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017095440A5 (https=) | ||
| MX2018003298A (es) | Metodo para preparar una formulacion de proteinas terapeuticas y formulacion de anticuerpos producida por tal metodo. | |
| AR082257A1 (es) | Composicion de inmunoglobulinas humanas concentradas, procedimiento | |
| Saso et al. | Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality? | |
| JP2016520075A5 (https=) | ||
| HRP20210743T1 (hr) | Hemisulfatna sol 5,10-metilen-(6r)-tetrahidrofolne kiseline | |
| UA102166C2 (ru) | Композиция для подкожного введения, которая содержит антитело к her2 | |
| JP2013531679A5 (https=) | ||
| RU2011127913A (ru) | Составы, содержащие антитела | |
| JP2014520852A5 (https=) | ||
| JP2016534052A5 (https=) | ||
| JP2013537518A5 (https=) | ||
| HRP20190954T1 (hr) | Stabilne formulacije imunoglobulinskih jednostrukih varijabilnih domena i njihove uporabe | |
| JP2013511481A5 (https=) | ||
| AR097840A1 (es) | Una formulación de un conjugado de la hormona de crecimiento humana de la actividad prolongada, procedimiento, kit | |
| JP2013530719A5 (https=) | ||
| CN111356476A (zh) | Lag-3抗体药物组合物及其用途 | |
| PE20210629A1 (es) | Anticuerpos anti-klk5 y metodos de uso | |
| JP2017525679A5 (https=) | ||
| JP2014519817A5 (https=) | ||
| JP2017525704A5 (https=) | ||
| CN110494164A (zh) | 一种靶向治疗TNF-α相关疾病的人抗体制剂 | |
| McCool et al. | Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope | |
| EA202092926A2 (ru) | Лиофилизированные составы, содержащие фактор ix | |
| IL265524B2 (en) | Assembled glycoproteins |